Our improved ability of profiling the molecular and genetic features of tumors has allowed for a better and more accurate detection of germline but also somatic, PVs in several genes, including BRCA1/2, resulting in a deeper understanding of the cancer risk related to heredo-familial tumor syndromes. This evidence concerns the gene BRCA1 and cancer.